Provided by Tiger Trade Technology Pte. Ltd.

ALPHAMAB-B

5.745
-0.200-3.36%
Volume:564.00K
Turnover:3.23M
Market Cap:5.54B
PE:-47.87
High:5.945
Open:5.945
Low:5.650
Close:5.945
52wk High:12.200
52wk Low:5.650
Shares:965.00M
HK Float Shares:965.00M
Volume Ratio:0.76
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.120
ROE:-9.98%
ROA:-5.47%
PB:2.82
PE(LYR):-47.87
PS:9.11

Loading ...

Alphamab Oncology Names CFO

MT Newswires Live
·
Nov 12

Alphamab Oncology Appoints David Ng as Chief Financial Officer

Reuters
·
Nov 12

Alphamab Oncology - Fei Wang Resigns as Chief Financial Officer of Alphamab Oncology

THOMSON REUTERS
·
Nov 12

Alphamab Oncology - Appointment of David Ng as CFO

THOMSON REUTERS
·
Nov 12

Alphamab Oncology Files Next Day Disclosure Return with HKEX Announcing Share Buyback

Reuters
·
Nov 11

Alphamab Oncology Adds 312,000 Shares to Treasury After HKD 1.97 Million On-Market Buyback

Bulletin Express
·
Nov 06

ALPHAMAB-B (09966) Spends Approximately HK$1.9721 Million to Buy Back 312,000 Shares on November 6

Stock News
·
Nov 06

Alphamab Oncology Files Next-Day Disclosure with HKEX Announcing Share Buyback

Reuters
·
Nov 06

Alphamab Oncology Adds 56,000 Shares to Treasury via HKEX Buyback, Utilising 0.29% of 2026 Repurchase Mandate

Bulletin Express
·
Nov 05

Alphamab Oncology Reports Share Buyback in HKEX Next Day Disclosure Return

Reuters
·
Nov 05

Alphamab-B (09966) Spends HK$367,000 to Buy Back 56,000 Shares on November 5

Stock News
·
Nov 05

Alphamab Oncology repurchases 160,000 shares, treasury stock climbs to 8.62 million

Bulletin Express
·
Nov 03

Alphamab-B (09966) Spends HK$977,500 to Buy Back 160,000 Shares on November 3

Stock News
·
Nov 03

Alphamab Oncology Discloses Share Buyback in HKEX Next Day Return

Reuters
·
Nov 03

Alphamab Oncology Repurchases 230,000 Shares for HK$1.39 Million, Boosting Treasury Stock to 8.46 Million

Bulletin Express
·
Nov 02

Alphamab-B (09966) Spends Approximately HK$1.3941 Million to Buy Back 230,000 Shares on November 2

Stock News
·
Nov 02

Alphamab Oncology Files Next-Day Disclosure with HKEX Announcing Share Buyback

Reuters
·
Nov 02

Alphamab Oncology: FDA Clears IND for Phase I Trial of Dual-Payload EGFR/HER3 ADC JSKN021

Bulletin Express
·
Nov 02

Alphamab-B's JSKN021 Phase I Clinical Study Receives FDA IND Approval

Stock News
·
Nov 02

Alphamab Oncology Gets FDA Approval for Jskn021 Phase I Trial

Reuters
·
Nov 02